Principal Investigator Dr. Lindsey Hoffman, Cincinnati Children’s Hospital, in collaboration with the Dana Farber Cancer Institute, Nationwide Children’s Hospital in Columbus and the Hospital for Sick Children in Toronto, will be exploring the genomic chafes between matched primary and progressive, recurrent or malignantly transformed PLGGs to guide the use of molecularly targeted therapies.

cchmc-logo (1)